Pediatr. praxi. 2007;8(6):336-342

Rotaviral infections

MUDr. Pavol Šimurka1, MUDr. Mária Štefkovičová PhD., MPH2, MUDr. Zuzana Krištúfková3
1 Pediatrická klinika, Fakultná nemocnica Trenčín
2 Regionálny ústav verejného zdravotníctva so sídlom v Trenčíne
3 Slovenská zdravotnícka univerzita Bratislava

Rotaviruses are the most common cause of diarrhoeal diseases in infants and small children worldwide, including European countries. Rotaviral gastroenteritis affects virtually all children up to 5 years of age. In developing countries it is the third most cause of mortality out of infectious causes in this age group. In developed countries, rotaviruses are responsible for high morbidity, increased hospital admissions due to acute gastroenteritis and present the most common cause of nosocomial infections in children. Preventive sanitary and epidemiological measures have only limited impact. The only way of prevention of clinically important cases is vaccination.

Keywords: rotavirus, rotavirus gastroenteritis, vaccination, Rotarix, Rotateq

Published: January 20, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šimurka P, Štefkovičová M, Krištúfková Z. Rotaviral infections. Pediatr. praxi. 2007;8(6):336-342.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ambrožová H. Klinický obraz dehydrovaného dítěte - terapie průjmů u kojenců. Klin Mikrobiol Inf Lék 1996; 2: 134-138.
    2. American Academy of Pediatrics. Rotavirus infections. In: Pickering LK, Baker CJ, Long SS, McMillan JA, eds. Red Book: Report of the committe on infectious diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006: 572-574.
    3. Avdičová M. Epidemiologická situácia v SR v roku 2006. RÚVZ Banská Bystrica, 2007.
    4. Bass ES, Pappano DA, Humiston SG. Rotavirus. Pediatrics in Review 2007; 28: 183-191. Go to original source... Go to PubMed...
    5. Bishop R, Davidson G, Holmes I et al. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet 1973; 2 (7841): 1281-1283. Go to original source... Go to PubMed...
    6. Clark HF, Offit PA, Glass RI, Ward RL. Rotavirus vaccine. In: Plotkin SA, Orenstein WA. Vaccines. 4th ed. Philadelphia: Elsevier Inc. (USA) 2004: 1327-1345.
    7. Giaquinto C, Van Damme P, Huet F et al. Clinical consequences of rotavirus acuta gastroenteritis in Europe, 2004-2005: The REVEAL Study. J Infect Dis 2007; 195 (Suppl 1): S26-S35. Go to original source... Go to PubMed...
    8. Glass RI, Parashar UD. The promise of new rotavirus vaccine. N Engl J Med 2006; 354: 75-77. Go to original source... Go to PubMed...
    9. Gleizes O, Desselberger U, Tatochenko V et al. Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. Pediatr Infect Dis J 2006; 25(Suppl): S12-S21. Go to original source... Go to PubMed...
    10. King CK, Glass R, Bresee JS, Duggan C. Centers for disease control and prevention. Managing acute gastroenteritis among children: oral rehydratation, maintance, and nutritional therapy. MMWR Recomm Rep 2003; 52(RR-16): 1-16.
    11. Lepage P. Rotavirus infection in Europe. Time for effective prevention? Pediatr Infect Dis J 2006; 25(Suppl): S5-S6. Go to original source... Go to PubMed...
    12. Parashar UD, Gibson CJ, Bresee JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg. Infect. Dis 2006; 12: 304-306. Go to original source... Go to PubMed...
    13. Pazdiora P, Táborská J. Průjmová onemocnění vyvolaná rotaviry. Praha: Grada Avicenum 2004. 144 s.
    14. Pazdiora P. Rotavirové infekce, současné možnosti očkování. Pediatrie pro praxi 2007; 2: 88-91.
    15. Rotavirus vaccines. WHO position paper. Weekly epidemiological Record 2007; 82: 285-296. Go to PubMed...
    16. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354: 11-22. Go to original source... Go to PubMed...
    17. Soriano-Gabarró M, Mrukowicz J, Vesikari T, Verstraeten T. Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J 2006; 25(Suppl): S7-S11. Go to original source... Go to PubMed...
    18. Šrámková L, Rýc M. Virové gastroenteritidy v klinické praxi. Praha: Grada Avicenum 1993. 160 s.
    19. Táborská J, Pazdiora P. Smecta a Lactobacillus ND v léčbě akutních dětských průjmů. Čs. Pediat. 1997; 52: 29-33.
    20. Van Damme P, Van der Wielen M, Ansaldi F. Rotavirus vaccines: considerations for successful implementation in Europe. Lancet Infect Dis 2006; 6: 805-812. Go to original source... Go to PubMed...
    21. Van Damme P. ESPID-ESPGHAN Rotavirus Expert Working Group. Evidence-based recommendations for use of rotavirus vaccines in Europe. 25th Annual Meeting of the ESPID, Porto, Portugal, 2007: s. 3 (abstrakt).
    22. Van Niel C, Feudtner C, Garrison M et al. Lactobacillus therapy for acute infectious diarrhoea in children: a meta-analysis. Pediatrics 2002; 109: 678-684. Go to original source... Go to PubMed...
    23. Vesikari T, Matson DO, Dennehy P et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354: 23-33. Go to original source... Go to PubMed...
    24. Zprávy CEM (SZÚ Praha) 2007; 16(1): 9.

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.